Roche is buying 89bio to get pegozafermin, a drug currently in two Phase 3 studies for the fatty liver disease MASH. Beyond the $2.4 billion payable when the deal closes, another $1.1 billion in contingent value right payments is tied to the achievement of commercial milestones for the projected blockbuster seller. The post Roche’s Metabolic…
[Sponsored] The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want. The post Changes in Nurse Staffing Answer Clinician Demands appeared first on MedCity News.
Sionna Therapeutics found strong investor interest in its cystic fibrosis drugs, which could rival blockbuster Vertex Pharmaceuticals product Trikafta. The biotech has three internally developed programs that hit a target unaddressed by any currently available CF therapies. The post Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline appeared first on…
About 1,500 federally funded health centers that serve millions of low-income people face significant financial challenges, their leaders say, as the government shutdown compounds other cuts to their revenue. Some of these community health centers may have to cut medical and administrative staff or reduce services. Some could eventually close. The result, their advocates warn,…
RIO GRANDE CITY, Texas — Jake Margo Jr. stood in the triage room at Starr County Memorial Hospital explaining why a person with persistent fever who could be treated with over-the-counter medication didn’t need to be admitted to the emergency room. “We’re going to take care of the sickest patients first,” Margo, a family medicine…
Cost effectiveness analyses (CEA) aim to examine how a new health technologies impact health outcomes and costs over a patient’s lifetime. While extrapolating long-run health benefits and measuring potential cost offsets are important, another important item to estimate is how the cost of the new health technology is likely to evolve over times. This is…
The Department of Health and Human Services’ mass dismissals of workers who release government records “raise grave transparency, accountability, and privacy concerns,” Oregon Sen. Ron Wyden said Thursday. In a May 8 letter to HHS Secretary Robert F. Kennedy Jr. provided exclusively to KFF Health News, Wyden, the top Democrat on the powerful Senate Finance…
That is the topic of a paper by Katherine Wagner (2022). The paper won the 2025 American Economic Journal: Economic Policy best papers award (despite being published 3 years ago). In her paper, Dr. Wagner uses data from 20 US Atlantic and Gulf Coast states between 2001 and 2017. Housing valuation data come from Zillow…
GLP-1 medications are transforming how we think about chronic disease management and, more importantly, prevention. Ongoing research has found them to be effective in the prevention or treatment of diabetes, heart attacks and strokes, kidney disease, liver disease, sleep apnea, and more. The post Diabetes Eradication? The New Chronic Condition Care Playbook and How GLP-1s…
Cigna’s new digital tools include an AI-powered virtual assistant, personalized provider matching and cost tracking. The post Cigna Launches 6 New Digital Tools To Improve Customer Experience appeared first on MedCity News.